American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc.

Share · US0287315032 (OTC)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of American Oriental Bioengineering, Inc.
No Price
Closing Price OTC 28.04.2026: 0,001 USD
28.04.2026 20:00
Current Prices from American Oriental Bioengineering, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
AOBI
USD
28.04.2026 20:00
0,001 USD
0,00 USD
Company Profile for American Oriental Bioengineering, Inc. Share
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

Company Data

Name American Oriental Bioengineering, Inc.
Company American Oriental Bioengineering, Inc.
Website http://www.bioaobo.com
Primary Exchange OTC UTC
ISIN US0287315032
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Shujun Liu
Country China
Currency USD
Employees 3,7 T
Address 1 First Liangshuihe Avenue, 100176 Beijing
IPO Date 2001-12-12

Stock Splits

Date Split
21.08.2014 1:501
03.04.2014 1:501
27.02.2012 1:2

Ticker Symbols

Name Symbol
Over The Counter AOBI
More Shares
Investors who hold American Oriental Bioengineering, Inc. also have the following shares in their portfolio:
BC Moly Ltd.
BC Moly Ltd. Share
Lux Real Estate Investments SA DL-Notes 2024(39) Series 1
Lux Real Estate Investments SA DL-Notes 2024(39) Series 1 Unbekannt